跳至主要内容
临床试验/KCT0008703
KCT0008703招募中Unknown

Prospective observational study in patients who will undergo myectomy due to hypertrophic cardiomyopathy

Asan Medical Center0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • Patients who are 18 years of age or older and diagnosed with hypertrophic cardiomyopathy and scheduled to undergo myectomy at Asan Medical Center until January 1st, 2027 after IRB approval

排除标准

  • Patients who are unable to provide informed consent for participation in the study or have diseases other than hypertrophic cardiomyopathy with a life expectancy of less than one year will be excluded.

研究者

相似试验

招募中
不适用
A prospective observational study for patients with community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia in a Japanese University Hospitalcommunity-acquired (CAP), health-care-associated (HCAP), hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)
JPRN-UMIN000007090Department of Respiratory Medicine, Nagoya University Graduate School of Medicine1,420
招募中
不适用
A prospective observational study in patients with chronic liver disease by magnetic resonance elastographyChronic liver disease
JPRN-UMIN000045236Musashino Red Cross Hospital1,000
已完成
不适用
A prospective observational study of patients with advanced cancer for the evaluation of checkpoint inhibitor-associated cardiovascular immune-related adverse eventsAdvanced non-small-cell lung cancer and advanced gastric cancer which are indications for anti-cytotoxic T-lymphocyte-associated antigen-4, anti-programmed death-1, and anti-programmed death-ligand 1 antibodies.
JPRN-UMIN000032729Frontline Immunotherapy Team, Sendai Kousei Hospital129
招募中
不适用
A prospective observational study of patients with ankle sprain and instability in Korean Medicine clinics and hospital
KCT0004016Gachon University200
尚未招募
Unknown
A Prospective Observational Study of patients who switched from SGLT2 inhibitor tablets to luseogliflozin OD film formulation in terms of feeling, Efficacy and Safety of taking the medicine.Type 2 Diabetes Mellitus
JPRN-UMIN000050476Seino internal Medicine Clinic60